WCN25-4621 Cilnidipine – a Novel CCB reduces blood pressure, heart rate and proteinuria in Indian Hypertensive Patients

WCN25-4621 Cilnidipine – a Novel CCB reduces blood pressure, heart rate and proteinuria in Indian Hypertensive Patients

Saved in:

Bibliographic Details
Main Authors:	Aafreen Naik, Deepak Dewan, Kapil Dev Metha
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924026664
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

WCN24-1558 A Retrospective, Electronic Medical Record Based Real World Evidence Study to assess the Effectiveness and Safety of Cilnidipine in Indian Hypertensive Patients
by: Aafreen Naik, et al.
Published: (2024-04-01)

WCN25-4499 Collagenofibrotic glomerulopathy – a rare cause of Nephrotic range proteinuria
by: SRISHTI RATHI, et al.
Published: (2025-02-01)

WCN25-927 PREVALENCE OF PROTEINURIA, HYPERTENSION, AND DIABETES IN AN INDIGENOUS POPULATION OF THE BIODIVERSE JUNGLE OF THE COLOMBIAN PACIFIC COAST
by: ROBERTO RAMIREZ MARMOLEJO, et al.
Published: (2025-02-01)

WCN25-3396 PREVALENCE OF PROTEINURIA IN SOUTHERN MALAYSIA: AN OBSERVATIONAL STUDY
by: XIAN PEI CHEONG, et al.
Published: (2025-02-01)

WCN25-4520 THE RELATIONSHIP BETWEEN PROTEINURIA, HEMATURIA, AND HISTOPATHOLOGICAL CHANGES IN LUPUS NEPHRITIS
by: Henrique Borges, et al.
Published: (2025-02-01)

WCN25-901 CLINICAL AND GENETIC CHARACTERISTICS CHILDREN WITH PROTEINURIA ASSOCIATED WITH CUBN VARIANTS
by: Larisa Prikhodina, et al.
Published: (2025-02-01)

Formulation and Evaluation of Polymeric Spherical Agglomerates-Based Porous Orodispersible Tablets of Cilnidipine
by: Yahya Alhamhoom, et al.
Published: (2025-01-01)

RETRACTED: Effect of antihypertensive agents ACEI/ARB and CCB on hypertensive intracerebral hemorrhage and inflammatory cytokines, serum ferritin, and serum P
by: Peiyu Li, et al.
Published: (2018-12-01)

Quantifying Proteinuria in Hypertensive Disorders of Pregnancy
by: Sapna V. Amin, et al.
Published: (2014-01-01)

Effects of Sacubitril/Valsartan on Blood Pressure and Proteinuria in Hypertensive Patients With Chronic Kidney Disease
by: Maki Murakoshi, et al.
Published: (2025-07-01)

WCN25-2709 MUTATIONAL SPECTRUM OF CTNS GENE IN INDIAN CHILDREN WITH NEPHROPATHIC CYSTINOSIS
by: Vishnu Dev, et al.
Published: (2025-02-01)

On-treatment systolic blood pressure and preserved kidney function in hypertensive patients with proteinuria. The VALUE Trial
by: Eirik Olsen, et al.
Published: (2025-12-01)

A Retrospective, Observational, EMR-Based Real-World Evidence Study to Assess the Incidence of Pedal Edema in Essential Hypertensive Patients on Amlodipine or Cilnidipine
by: Jamshed Dalal, et al.
Published: (2022-01-01)

Cilnidipine exerts antiviral effects in vitro and in vivo by inhibiting the internalization and fusion of influenza A virus
by: Yinyan Li, et al.
Published: (2025-04-01)

Analysis of decayed Norway spruce wood impregnated with CCB after 14 years of outdoor exposure
by: Miha Humar, et al.
Published: (2021-05-01)

WCN25-52 EPIDEMIOLOGY OF IMMUNOGLOBULIN A NEPHROPATHY (IgAN) AND OCCURRENCE OF PROTEINURIA IN CHINA: EVIDENCE FROM SYSTEMATIC REVIEW AND META-ANALYSIS
by: Zhaoxin Chen, et al.
Published: (2025-02-01)

WCN25-2556 OCCUPATIONAL HEALTH RISKS AND RENAL DYSFUNCTION IN NORTH INDIAN AUTO-RICKSHAW DRIVERS
by: ANISH GUPTA, et al.
Published: (2025-02-01)

WCN25-120 Effect of Intravitreal Bevacizumab on Renal Function and Proteinuria Among Diabetic Patients: A Prospective Observational Study in North India
by: Raj Kanwar Yadav, et al.
Published: (2025-02-01)

WCN25-2084 EVALUATION OF TUBULOGLOMERULAR OUTCOME BY MEASURING PROTEINURIA AND URINARY NGAL AFTER INDUCTION BY MMF IN CLASS III/IV LUPUS NEPHRITIS
by: Md. Aminul Haq, et al.
Published: (2025-02-01)

WCN25-399 CLINICAL PROFILE AND OUTCOME OF AA AMYLOIDOSIS IN INDIAN PATIENTS
by: Akash Sarkar, et al.
Published: (2025-02-01)

WCN25-716 EFFECT OF IPTACOPAN ON PROTEINURIA AND COMPLEMENT BIOMARKERS IN IgA NEPHROPATHY (IgAN): INTERIM ANALYSIS OF THE PHASE 3 APPLAUSE-IgAN STUDY
by: Dmitrij Kollins, et al.
Published: (2025-02-01)

WCN25-945 PROGNOSTIC OF THE PERSISTENCE OF HEMATURIA AND PROTEINURIA AFTER INDUCTION IN VASCULITIS ASSOCIATED WITH ANCA IN THE NEPHROLOGY SERVICE, HOSPITAL DE CLÍNICAS UNIVERSITARIO, BOLIVIA
by: Luis Alberto Céspedes Limachi, et al.
Published: (2025-02-01)

WCN24-2673 COMPLEMENT LEVELS AND PROTEINURIA IN LUPUS NEPHRITIS CORRELATIONS AND TREATMENT RESPONSE
by: Maria Izabel de Holanda, et al.
Published: (2024-04-01)

WCN25-4521 A Multicentre Prospective Observational Study of Ambulatory Blood Pressure Monitoring in Indian Patients With and Without Chronic Kidney Disease
by: Arvind Conjeevaram, et al.
Published: (2025-02-01)

WCN25-2999 THE GENETIC LANDSCAPE OF ALPORT SYNDROME IN INDIAN PATIENTS WITH PHENOTYPIC CORRELATION
by: Trishla Jadon, et al.
Published: (2025-02-01)

WCN25-4565 PROLIFERATIVE GLOMERULONEPHRITIS IN THE ELDERLY: AN OBSERVATIONAL STUDY FROM NORTHERN INDIAN
by: Abdullah Ansari, et al.
Published: (2025-02-01)

WCN25-2461 CLINICAL AND MORPHOLOGICAL CHARACTERSTICS OF LECT2 AMYLOIDOSIS IN INDIAN POPULATION
by: Seema Rahar, et al.
Published: (2025-02-01)

WCN25-3835 WHICH GFR FORMULA IS MOST ACCURATE IN INDIAN CIRRHOTIC POPULATION?
by: Smita Divyaveer, et al.
Published: (2025-02-01)

WCN25-1898 IMPLICATIONS OF PROTEINURIA REMISSION ON ESTIMATED GLOMERULAR FILTRATION RATE (eGFR) TRAJECTORY IN PATIENTS (Pts) WITH IgA NEPHROPATHY (IgAN) IN PROTECT
by: Bruce Hendry, et al.
Published: (2025-02-01)

Prevalence, socio-demographic and environmental determinants of asthma in 4621 Ghanaian adults: Evidence from Wave 2 of the World Health Organization's study on global AGEing and adult health.
by: Justice Moses K Aheto, et al.
Published: (2020-01-01)

WCN25-1963 CLINICAL SPECTRUM AND OUTCOME OF ACCELERATED HYPERTENSION IN CHILDREN
by: Alok Kumar, et al.
Published: (2025-02-01)

WCN25-3908 WHEN HYPERTENSION HIDES A DEADLY SECRET
by: Aleena Rose Joy, et al.
Published: (2025-02-01)

WCN25-932 STEROID (SYSTEMIC OR ENTERIC RELEASED BUDESONIDE) REFRACTORY NEPHROTIC RANGE PROTEINURIA IN IgA NEPHROPATHY; CAN TACROLIMUS BE AN ALTERNATIVE?- A CASE SERIES
by: RAJA SINGHAL, et al.
Published: (2025-02-01)

Chylous Urine with Massive Proteinuria – Not Every Proteinuria Requires Renal Biopsy!
by: Siddharth Herur, et al.
Published: (2023-07-01)

WCN25-2509 GENETIC VARIANTS ASSOCIATED WITH CHRONIC KIDNEY DISEASE (CKD) IN AN INDIAN POPULATION
by: Mythri Shankar, et al.
Published: (2025-02-01)

WCN25-4378 OUTCOME OF USE OF ENTERIC RELEASED BUDESONIDE IN IgA NEPHROPATHY PATIENTS WITH NEPHROTIC AND SUBNEPHROTIC PROTEINURIA PRESENTATIONS: PROSPECTIVE COMPARATIVE STUDY IN TERTIARY CARE CENTRE
by: RAJA SINGHAL, et al.
Published: (2025-02-01)

WCN24-2352 Improved Proteinuria Reduction with the use of Sparsentan and Targeted Release Budesonide in advanced IgAN
by: Neeharik Mareedu, et al.
Published: (2024-04-01)

Clinical pathophysiology of proteinuria
by: A. Gozhenko, et al.
Published: (2024-03-01)

Isolated Proteinuria in Asymptomatic
by: Akinkugbe FM, et al.
Published: (2024-06-01)

Evaluación y usos de dos especies forestales aptas para postes rollizos tratados con xilocrón (ccb) por inmersión
by: Juan B. Tuk-Durán
Published: (2019-02-01)